Levy Guy purchased $10.0M of PBLS (indirect holdings)
Levy Guy purchased 500,000 indirectly-held shares of Parabilis Medicines, Inc. (PBLS) at $20.00 ($10.00M total) across 2 trades on 2026-06-11.
How this was made
The 30-second read
Why it matters
The newest fact is the disclosed $10.0M open-market purchase by a 10% owner at a fixed $20.00/share price, with holdings rising to 652,000 shares.
Market read
Traders may treat the disclosure as a modest positive sentiment input, but it does not replace fundamental catalysts.
What to watch
Indirect holdings and the absence of a 10b5-1 plan detail can complicate interpretation; traders should avoid extrapolating to near-term fundamental re-rating without additional catalysts.
Background
The article is an SEC Form 4 insider transaction disclosure for Parabilis Medicines, Inc. (PBLS).
Ticker impact
SEC Form 4 shows 10% owner Levy Guy bought $10.0M of Parabilis Medicines shares at $20.00 on 2026-06-11 (indirect holdings).
Near-term: limited/mostly sentiment-driven; follow-through depends on subsequent company-specific news.
The filing is primary-source and sizable ($10M), but it lacks new fundamentals (no guidance, trial, deal, or regulatory action) and is disclosed after the trade date.
Market effects
Minimal; this is company-specific ownership activity with no sector-wide datapoint.
None indicated.
None indicated.
Counterpoint
A 10% owner purchase may be part of pre-planned liquidity/portfolio management rather than a strong forward-looking signal (notably, no 10b5-1 plan is cited).
Key entities
- issuerParabilis Medicines, Inc.
Subject of the Form 4 insider transaction disclosure (PBLS).
- insiderLevy Guy
Reporter; 10% owner who purchased 500,000 shares indirectly at $20.00/share on 2026-06-11.
